ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in January 2026. Updated January 8.
A roundup of FDA’s actions in January 2026.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in January 2026. Updated January 8.
A roundup of FDA’s actions in January 2026.